LUPIN
|
LUPIN Last 5 Year Financial Ratios History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 71.87 | 42.01 | 9.45 | -33.62 | 26.81 |
CEPS(Rs) | 98.02 | 68.74 | 29.20 | 3.29 | 46.62 |
DPS(Rs) | 12.00 | 8.00 | 4.00 | 4.00 | 6.50 |
Book NAV/Share(Rs) | 374.93 | 311.08 | 270.67 | 263.84 | 300.06 |
Tax Rate(%) | 17.65 | 20.09 | 37.52 | -9.99 | 26.75 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 14.19 | 11.94 | 6.05 | 0.73 | 9.08 |
EBIT Margin(%) | 11.59 | 8.61 | 3.48 | -4.14 | 6.43 |
Pre Tax Margin(%) | 10.80 | 7.63 | 2.52 | -4.62 | 5.93 |
PAT Margin (%) | 8.89 | 6.10 | 1.57 | -5.09 | 4.34 |
Cash Profit Margin (%) | 12.04 | 9.87 | 4.67 | 0.50 | 7.48 |
Performance Ratios | |||||
ROA(%) | 12.63 | 8.33 | 2.01 | -6.70 | 5.09 |
ROE(%) | 21.13 | 14.61 | 3.68 | -11.79 | 9.47 |
ROCE(%) | 21.97 | 16.24 | 6.06 | -7.11 | 9.71 |
Asset Turnover(x) | 1.42 | 1.37 | 1.28 | 1.32 | 1.17 |
Sales/Fixed Asset(x) | 1.87 | 1.68 | 1.67 | 1.93 | 1.96 |
Working Capital/Sales(x) | 4.74 | 6.42 | 8.93 | 7.10 | 5.09 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.54 | 0.59 | 0.60 | 0.52 | 0.51 |
Receivable days | 50.00 | 52.75 | 56.09 | 53.73 | 64.06 |
Inventory Days | 51.19 | 54.32 | 58.53 | 53.64 | 48.75 |
Payable days | 185.58 | 177.49 | 144.07 | 132.55 | 161.68 |
Valuation Parameters | |||||
PER(x) | 28.20 | 38.51 | 68.54 | - | 38.08 |
PCE(x) | 20.67 | 23.54 | 22.19 | 227.04 | 21.90 |
Price/Book(x) | 5.40 | 5.20 | 2.39 | 2.83 | 3.40 |
Yield(%) | 0.59 | 0.49 | 0.62 | 0.54 | 0.64 |
EV/Net Sales(x) | 4.16 | 3.76 | 1.95 | 2.23 | 3.26 |
EV/Core EBITDA(x) | 17.24 | 19.13 | 17.33 | 85.46 | 18.26 |
EV/EBIT(x) | 21.92 | 27.50 | 32.73 | -29.81 | 27.16 |
EV/CE(x) | 4.24 | 4.43 | 1.94 | 1.69 | 2.11 |
M Cap / Sales | 4.07 | 3.68 | 1.77 | 2.07 | 3.05 |
Growth Ratio | |||||
Net Sales Growth(%) | 13.48 | 20.25 | 1.44 | 8.19 | -1.38 |
Core EBITDA Growth(%) | 39.39 | 110.03 | 336.33 | -84.13 | -4.77 |
EBIT Growth(%) | 57.65 | 175.93 | 180.59 | -167.66 | 62.21 |
PAT Growth(%) | 70.82 | 332.35 | 129.66 | -222.92 | 407.07 |
EPS Growth(%) | 71.07 | 344.46 | 128.11 | -225.39 | 550.89 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | 0.30 | 0.19 | 0.34 | 0.32 | 0.35 |
Current Ratio(x) | 1.87 | 1.58 | 1.34 | 1.51 | 1.66 |
Quick Ratio(x) | 1.26 | 1.00 | 0.86 | 0.95 | 1.17 |
Interest Cover(x) | 14.62 | 8.77 | 3.61 | -8.61 | 12.92 |
Total Debt/Mcap(x) | 0.05 | 0.04 | 0.14 | 0.11 | 0.10 |
Compare Financial Ratios of peers of LUPIN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LUPIN | ₹89,944.8 Cr | 2.3% | 1.6% | -5.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,667.0 Cr | 3.5% | -3.4% | -5.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,697.0 Cr | 3.7% | -10.2% | 25.6% | Stock Analytics | |
CIPLA | ₹126,365.0 Cr | 5.3% | 6.1% | -1.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,639.0 Cr | 1.4% | 4.6% | 7.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,479.0 Cr | 3.9% | 0% | -9.9% | Stock Analytics |
LUPIN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LUPIN | 2.3% |
1.6% |
-5.3% |
SENSEX | 1.8% |
-1.7% |
2.9% |
You may also like the below Video Courses